GlassScriptPhysician profile
Christopher Brian Paul
NPI 1114199932
$1,781.15
in general payments reported to CMS, 2019-2025
16 companies · $933 in 2025
The $933 reported for 2025 was more than what 94% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.50 · 2020: $92.72 · 2021: $23.91 · 2022: $176 · 2023: $216 · 2024: $326 · 2025: $933.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,016 · Travel and Lodging: $459.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,016.28 |
| Travel and Lodging | $459.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mml US, INC. | $761.73 | 2023-2025 | Reactiv8 |
| Medtronic, INC. | $271.61 | 2023-2025 | Venaseal, Na, Bis |
| Edwards Lifesciences Corporation | $199.09 | 2022-2023 | Hemosphere |
| Abbott Laboratories | $177.47 | 2024 | Proclaim |
| Nalu Medical, INC. | $134.68 | 2025 | Nalu Neurostimulation System |
| Merck Sharp & Dohme LLC | $58.00 | 2019-2025 | Bridion |
| Arbor Pharmaceuticals, INC. | $30.99 | 2020 | |
| Saluda Medical Americas, INC. | $28.92 | 2025 | Evoke |
| Redhill Biopharma INC. | $20.77 | 2020 | |
| Fisher & Paykel Healthcare INC | $17.90 | 2024 | Fisher & Paykel Healthcare |
| Ibsa Pharma INC. | $16.67 | 2020 | |
| Chiesi USA, INC. | $15.12 | 2023 | Kengreal, Cleviprex |
| Forte Bio-Pharma LLC | $13.86 | 2021 | |
| Eisai INC. | $12.52 | 2020 | |
| Pfizer INC. | $11.77 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merit Medical Systems INC | $10.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Paul listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.